T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial

BACKGROUND: T-cell vaccination (TCV) for multiple sclerosis (MS) refers to treatment with autologous anti-myelin T-cells, attenuated by irradiation. Previously published clinical trials have been all open-labeled. AIM: To evaluate the safety and efficacy of TCV in progressive MS, in a double-blind,...

Descripción completa

Detalles Bibliográficos
Autores principales: Karussis, Dimitrios, Shor, Hagai, Yachnin, Julia, Lanxner, Naama, Amiel, Merav, Baruch, Keren, Keren-Zur, Yael, Haviv, Ofra, Filippi, Massimo, Petrou, Panayiota, Hajag, Shalom, Vourka-Karussis, Urania, Vaknin-Dembinsky, Adi, Khoury, Salim, Abramsky, Oded, Atlan, Henri, Cohen, Irun R., Abulafia-Lapid, Rivka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522721/
https://www.ncbi.nlm.nih.gov/pubmed/23272061
http://dx.doi.org/10.1371/journal.pone.0050478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522721/
https://www.ncbi.nlm.nih.gov/pubmed/23272061
http://dx.doi.org/10.1371/journal.pone.0050478

Ejemplares similares